STEMTECH CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0535 USD | -12.94% |
|
-25.28% | +64.62% |
Financials (USD)
| Sales 2021 | 4.32M | Sales 2022 | 4.56M | Capitalization | 4.62M |
|---|---|---|---|---|---|
| Net income 2021 | -7M | Net income 2022 | -8M | EV / Sales 2021 | 24.7 x |
| Net Debt 2021 | 622K | Net Debt 2022 | 1.15M | EV / Sales 2022 | 1.27 x |
| P/E ratio 2021 |
-12.5
x | P/E ratio 2022 |
-0.47
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 62.54% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -12.94% | ||
| 1 week | -25.28% | ||
| Current month | -31.85% | ||
| 1 month | -38.43% | ||
| 3 months | +82.59% | ||
| 6 months | +52.42% | ||
| Current year | +64.62% |
1 week
0.05
0.07
1 month
0.050.10
Current year
0.030.10
1 year
0.020.10
3 years
0.0211.50
5 years
0.0211.50
10 years
0.0211.50
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 0.0614 | -4.13% | 80,619 |
| 24-04-19 | 0.0641 | +1.75% | 163,091 |
| 24-04-18 | 0.063 | -15.21% | 175,789 |
| 24-04-17 | 0.0743 | +3.77% | 184,949 |
| 24-04-16 | 0.0716 | +0.21% | 166,479 |
Delayed Quote OTC Markets, April 23, 2024 at 03:04 pm EDT
More quotes
Stemtech Corporation is a global network marketing company that develops science-based products, which support wellness by helping the body maintain healthy stem cell physiology, also known as stem cell enhancers. The Company is also known as Stem Cell Nutrition Company. The Company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where they can perform their daily function of renewal for optimal health. These products are marketed internationally by the Companies subsidiaries and through independent distributors. The Company markets its products under various brands, which include RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze (Electromagnetic Frequency blocker). It also introduced a skincare product, Cellect One Rapid Renew Stem Cell Peptide Night Cream. Its segments include North America, Latin America and Asia.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +64.62% | 7.18M | |
| -2.68% | 85.68B | |
| +4.08% | 41.4B | |
| -25.35% | 28.22B | |
| +54.31% | 24.64B | |
| -4.52% | 16.98B | |
| -42.09% | 13.29B | |
| -17.77% | 11.66B | |
| -12.10% | 11.65B | |
| +0.75% | 8.18B |
- Stock Market
- Equities
- STEK Stock
